±á³Ü²¹?²Ñ±ð»å¾±³¦¾±²Ô±ð?(³Ù³ó±ð?¡°°ä´Ç³¾±è²¹²Ô²â¡±,?±á°·¡³æ:?2552)?²¹²Ô²Ô´Ç³Ü²Ô³¦±ð»å?³Ù³ó±ð?³Ü²Ô²¹³Ü»å¾±³Ù±ð»å?³¦´Ç²Ô²õ´Ç±ô¾±»å²¹³Ù±ð»å?°ù±ð²õ³Ü±ô³Ù²õ?´Ç´Ú?³Ù³ó±ð?°ä´Ç³¾±è²¹²Ô²â?²¹²Ô»å?¾±³Ù²õ?²õ³Ü²ú²õ¾±»å¾±²¹°ù¾±±ð²õ?´Ú´Ç°ù?³Ù³ó±ð?²õ¾±³æ?³¾´Ç²Ô³Ù³ó²õ?±ð²Ô»å±ð»å?´³³Ü²Ô±ð?30,?2025?(³Ù³ó±ð?¡°¸é±ð±è´Ç°ù³Ù¾±²Ô²µ?±Ê±ð°ù¾±´Ç»å¡±),?²¹²õ?·É±ð±ô±ô?²¹²õ?³Ù³ó±ð?°ä´Ç³¾±è²¹²Ô²â'²õ?²ú³Ü²õ¾±²Ô±ð²õ²õ?±è°ù´Ç²µ°ù±ð²õ²õ?»å³Ü°ù¾±²Ô²µ?³Ù³ó±ð?´Ú¾±°ù²õ³Ù?³ó²¹±ô´Ú?´Ç´Ú?³Ù³ó±ð?²â±ð²¹°ù?²¹²Ô»å?´Ú³Ü³Ù³Ü°ù±ð?´Ç³Ü³Ù±ô´Ç´Ç°ì.?
Hua?Medicine?(the?"Company",?Hong?Kong?Stock?Exchange?Stock?Code:?2552)?announced?yesterday?a?positive?profit?alert?for?the?first?half?of?the?year?for?the?Company?together?with?its?subsidiaries.?(the?"Group").
Hua?Medicine?("the?Company",?stock?code:?2552.HK)?announced?today?that?the?Company?presented?the?latest?research?results?of?dorzagliatin,?its?global?first-in-class?glucokinase?activator?(GKA),?at?the?85th?Scientific?Sessions?of?the?American?Diabetes?Association?(ADA).
ir@huamedicine.com
No.275 Ai Di Sheng Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203
Privacy Statement Terms of Use
